Concord Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-114
| Closed | -$4K | – | 217 |
|
|
2022
Q2 | $4K | Buy |
114
+14
| +14% | +$491 | ﹤0.01% | 848 |
|
|
2022
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 895 |
|
|
2021
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 892 |
|
|
2021
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 523 |
|
|
2021
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 635 |
|
|
2021
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 592 |
|
|
2020
Q4 | $9K | Buy |
+100
| New | +$9K | 0.01% | 366 |
|